248 bytes added
	
		,  15:56, 18 July 2022
	
 
* Renal excretion. Acts on COX 1/2. Inhibits renal production of prostaglandins. 
* Safe for short term use in patients with stage 1-2 CKD. Risk of causing AKI is same as in general population. No evidence that it will increase risk of progression.